High-Dose Exercise for Concussion Recovery
(MEDIC Trial)
Trial Summary
What is the purpose of this trial?
Aerobic exercise has emerged as an effective treatment to reduce sport-related concussion symptom severity, yet existing work lacks rigor regarding the precise exercise volume and intensity required to elicit therapeutic effects, how exercise can alter concussion-related pathophysiology, and whether exercise can prevent the development of secondary sequelae. Our objective is to examine if a high dose exercise program (higher volume than currently prescribed at an individualized, safe intensity level) initiated within 14 days of concussion results in faster symptom resolution, altered physiological function, or reduced secondary sequalae. Findings from this research will lead to more rigorous and precise rehabilitation guidelines and improved understanding about how exercise affects neurophysiological function among adolescents with concussion.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High Dose Exercise, Aerobic Exercise, High-Intensity Aerobic Exercise, Subsymptom Threshold Aerobic Exercise for concussion recovery?
Research suggests that aerobic exercise, when done below the level that worsens symptoms, can help speed up recovery from a concussion. Studies have shown that early controlled aerobic exercise is safe and may reduce the duration of symptoms, helping individuals return to normal activities faster.12345
Is high-dose exercise safe for concussion recovery?
How does high-dose exercise differ from other treatments for concussion recovery?
High-dose exercise for concussion recovery is unique because it involves aerobic exercise at a level just below the threshold that would trigger symptoms, which is different from the traditional approach of complete rest. This method aims to improve recovery by gradually reintroducing physical activity, potentially reducing symptoms and improving psychological well-being without adverse effects.12369
Research Team
David R Howell, PhD
Principal Investigator
University of Colorado Denver | Anschutz
Eligibility Criteria
This trial is for teens aged 13-18 who have been diagnosed with a concussion by a sports medicine physician and are still experiencing symptoms (PCSS score >10). It's not suitable for those with pre-existing neurological disorders, exercise contraindications, or another concussion in the last 6 months.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to high dose aerobic exercise or standard-of-care, with exercise recommendations adjusted upon symptom resolution
Follow-up
Participants are monitored for safety and effectiveness after treatment, including serum biomarker and cerebrovascular function assessments
Treatment Details
Interventions
- High Dose Exercise (Behavioral Intervention)
High Dose Exercise is already approved in Canada for the following indications:
- Sport-related concussion recovery
- Reduction of concussion symptom severity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences
Boston Children's Hospital
Collaborator
Dr. Kevin B. Churchwell
Boston Children's Hospital
Chief Executive Officer since 2021
MD from Vanderbilt Medical School
Dr. Sarah Pitts
Boston Children's Hospital
Chief Medical Officer since 2019
MD from Harvard Medical School
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland
Spaulding Rehabilitation Hospital
Collaborator
Greg Jackson
Spaulding Rehabilitation Hospital
Interim President and Chief Operating Officer
Bachelor's degree in Psychology and Master's in Rehabilitation Counseling from Arkansas State University
Cheri Blauwet
Spaulding Rehabilitation Hospital
Chief Medical Officer
MD